CHEK Check-Cap Ltd
19,569
$2.20
$0.0044
(0.20%)
| Watchers | 19,569 |
| 52-Wk Low | $1.30 |
| 52-Wk High | $4.63 |
| Market Cap | $12.87M |
| Volume | 5,119.00 |
| 52-Wk High | $4.63 |
| 52-Wk Low | $1.30 |
Check-Cap Ltd. Calls Shareholders to Vote on Key ProposalsTipRanks Financial Blog • about 1 month ago
Check-Cap Ltd. (CHEK) has released an update. Check-Cap Ltd., an Israeli company, has announced an Extraordinary General Meeting of Shareholders to...
Share to Feed
StockNews.com started coverage on shares of Check-Cap (NASDAQ:CHEK Free Report) in a research note released on Friday morning. The firm issued a sell rating on the medical research...
Check-Cap shares surge as Nobul AI Corp agrees to acquire it, forming a new public entity focused on AI-driven fintech solutions. Pending completion, the merged company aims for NASDAQ and TSX...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement Canada NewsWire TORONTO...
Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement PR Newswire TORONTO, March...
Research analysts at StockNews.com initiated coverage on shares of Check-Cap (NASDAQ:CHEK Get Free Report) in a research report issued to clients and investors on Friday. The firm set a...
Research analysts at StockNews.com started coverage on shares of Check-Cap (NASDAQ:CHEK Get Free Report) in a research report issued on Thursday. The firm set a sell rating on...
StockNews.com assumed coverage on shares of Check-Cap (NASDAQ:CHEK Free Report) in a report issued on Thursday. The firm issued a sell rating on the medical research companys...
StockNews.com initiated coverage on shares of Check-Cap (NASDAQ:CHEK Free Report) in a report published on Wednesday morning. The firm issued a sell rating on the medical research...